The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WHO classification of tumours of the lung, pleura, thymus and heart
Travis, W. D. (2015) · International Agency for Research on Cancer eBooks · Cited by 1,664
Frequent Mutation of BAP1 in Metastasizing Uveal Melanomas
Harbour, J. W., Onken, M. D., Roberson, E. D. O., Duan, S., Cao, L., Worley, L. A., Council, M. L., Matatall, K. A., Helms, C., & Bowcock, A. M. (2010) · Science · doi:10.1126/science.1194472 · Cited by 1,462
The European mesothelioma epidemic
Peto, J., Decarli, A., Vecchia, C. L., Levi, F., & Negri, E. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690105 · Cited by 891
Germline mutations in BAP1 predispose to melanocytic tumors
Wiesner, T., Obenauf, A. C., Murali, R., Fried, I., Griewank, K. G., Ulz, P., Windpassinger, C., Wackernagel, W., Loy, S., Wolf, I., et al. (2011) · Nature Genetics · doi:10.1038/ng.910 · Cited by 725
Jensen, D. E., Proctor, M., Marquis, S. T., Gardner, H. P., Ha, S. I., Chodosh, L. A., Ishov, A. M., Tommerup, N., Vissing, H., Sekido, Y., et al. (1998) · Oncogene · doi:10.1038/sj.onc.1201861 · Cited by 723
Bott, M., Brevet, M., Taylor, B. S., Shimizu, S., Ito, T., Wang, L., Creaney, J., Lake, R. A., Zakowski, M. F., Reva, B., et al. (2011) · Nature Genetics · doi:10.1038/ng.855 · Cited by 717
Carbone, M., Yang, H., Pass, H. I., Krausz, T., Testa, J. R., & Gaudino, G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3459 · Cited by 590
Husain, A. N., Colby, T., Ordonez, N., Krausz, T., Attanoos, R., Beasley, M. B., Borczuk, A. C., Butnor, K., Cagle, P. T., Chirieac, L. R., et al. (2013) · Archives of Pathology and Laboratory Medicine · doi:10.5858/arpa.2012-0214-oa · Cited by 473
Tumor suppressor and deubiquitinase BAP1 promotes DNA double-strand break repair
Yu, H., Pak, H., Hammond-Martel, I., Ghram, M., Rodrigue, A., Daou, S., Barbour, H., Corbeil, L., Hébert, J., Drobetsky, E., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1309085110 · Cited by 383
Ventii, K. H., Devi, N. S., Friedrich, K. L., Chernova, T. A., Tighiouart, M., Van Meir, E. G., & Wilkinson, K. D. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0365 · Cited by 334
Shen, S.-X., Weaver, Z., Xu, X., Li, C., Weinstein, M., Chen, L., Guan, X.-Y., Ried, T., & Deng, C.-X. (1998) · Oncogene · doi:10.1038/sj.onc.1202243 · Cited by 329
High Incidence of Somatic BAP1 Alterations in Sporadic Malignant Mesothelioma
Nasu, M., Emi, M., Pastorino, S., Tanji, M., Powers, A., Luk, H., Baumann, F., Zhang, Y.-A., Gazdar, A., Kanodia, S., et al. (2015) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000471 · Cited by 326
BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs
Carbone, M., Ferris, L. K., Baumann, F., Napolitano, A., Lum, C. A., Flores, E. G., Gaudino, G., Powers, A., Bryant-Greenwood, P., Krausz, T., et al. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-179 · Cited by 323
Guo, G., Chmielecki, J., Goparaju, C., Heguy, A., Dolgalev, I., Carbone, M., Seepo, S., Meyerson, M., & Pass, H. I. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-1008 · Cited by 321
Wiesner, T., Murali, R., Fried, I., Cerroni, L., Busam, K., Kutzner, H., & Bastian, B. C. (2012) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3182498be5 · Cited by 279
The deubiquitinating enzyme BAP1 regulates cell growth via interaction with HCF-1
Machida, Y. J., Machida, Y., Vashisht, A. A., Wohlschlegel, J. A., & Dutta, A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.046755 · Cited by 274
Mesothelioma Epidemiology, Carcinogenesis, and Pathogenesis
Yang, H., Testa, J. R., & Carbone, M. (2008) · Current Treatment Options in Oncology · doi:10.1007/s11864-008-0067-z · Cited by 274
The Separation of Benign and Malignant Mesothelial Proliferations
(2000) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200009000-00001 · Cited by 272
Price, B. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh025 · Cited by 271
Yu, H., Mashtalir, N., Daou, S., Hammond-Martel, I., Ross, J., Sui, G., Hart, G. W., Rauscher, F. J., Drobetsky, E., Milot, E., et al. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00396-10 · Cited by 270
BRCA1-Associated Protein 1 Interferes with BRCA1/BARD1 RING Heterodimer Activity
Nishikawa, H., Wu, W., Koike, A., Kojima, R., Gomi, H., Fukuda, M., & Ohta, T. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3355 · Cited by 221
Attanoos, R. L., Griffin, A., & Gibbs, A. R. (2003) · Histopathology · doi:10.1046/j.1365-2559.2003.01686.x · Cited by 217
Germline Mutations in BAP1 Impair Its Function in DNA Double-Strand Break Repair
Ismail, I. H., Davidson, R., Gagné, J.-P., Xu, Z. Z., Poirier, G. G., & Hendzel, M. J. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3109 · Cited by 215
Diagnostic importance of 9p21 homozygous deletion in malignant mesotheliomas
Chiosea, S., Krasinskas, A., Cagle, P. T., Mitchell, K. A., Zander, D. S., & Dacic, S. (2008) · Modern Pathology · doi:10.1038/modpathol.2008.45 · Cited by 207
BAP1 Immunohistochemistry and p16 FISH to Separate Benign From Malignant Mesothelial Proliferations
Sheffield, B. S., Hwang, H. C., Lee, A. F., Thompson, K., Rodriguez, S., Tse, C. H., Gown, A. M., & Churg, A. (2015) · American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000394 · Cited by 187
Frequent inactivation of the BAP1 gene in epithelioid‐type malignant mesothelioma
Yoshikawa, Y., Sato, A., Tsujimura, T., Emi, M., Morinaga, T., Fukuoka, K., Yamada, S., Murakami, A., Kondo, N., Matsumoto, S., et al. (2012) · Cancer Science · doi:10.1111/j.1349-7006.2012.02223.x · Cited by 179
Joseph, R. W., Kapur, P., Serie, D. J., Eckel‐Passow, J. E., Parasramka, M., Ho, T., Cheville, J. C., Frenkel, E., Rakheja, D., Brugarolas, J., et al. (2014) · Cancer · doi:10.1002/cncr.28521 · Cited by 161
Hasteh, F., Lin, G., Weidner, N., & Michael, C. W. (2010) · Cancer Cytopathology · doi:10.1002/cncy.20071 · Cited by 158
de Reyniès, A., Jaurand, M., Renier, A., Couchy, G., Hysi, I., Elarouci, N., Galateau-Sallé, F., Copin, M., Hofman, P. M., Cazes, A., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2429 · Cited by 157
Vermi, W., Lonardi, S., Morassi, M., Rossini, C., Tardanico, R., Venturini, M., Sala, R., Tincani, A., Poliani, P. L., Calzavara‐Pinton, P., et al. (2009) · Immunobiology · doi:10.1016/j.imbio.2009.06.013 · Cited by 156
Self-citationSarcomatoid Neoplasms of the Lung and Pleura
Travis, W. D. (2010) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2010-0086-rar.1 · Cited by 146
Germline Mutation of Bap1 Accelerates Development of Asbestos-Induced Malignant Mesothelioma
Xu, J., Kadariya, Y., Cheung, M., Pei, J., Talarchek, J., Sementino, E., Tan, Y., Menges, C. W., Cai, K. Q., Litwin, S., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1328 · Cited by 144
Sarcomatoid mesothelioma: a clinical–pathologic correlation of 326 cases
Klebe, S., Brownlee, N. A., Mahar, A. M., Burchette, J. L., Sporn, T. A., Vollmer, R. T., & Roggli, V. L. (2010) · Modern Pathology · doi:10.1038/modpathol.2009.180 · Cited by 143
Kato, Y., Tsuta, K., Seki, K., Maeshima, A. M., WATANABE, S.-I. I., Suzuki, K., Asamura, H., Tsuchiya, R., & Matsuno, Y. (2006) · Modern Pathology · doi:10.1038/modpathol.3800732 · Cited by 140
Sarcomatoid mesothelioma and its histological mimics: a comparative immunohistochemical study
Lucas, D. R., Pass, H. I., Madan, S. K., Adsay, V. N., Wali, A., Tabaczka, P. M., & Lonardo, F. (2003) · Histopathology · doi:10.1046/j.1365-2559.2003.01583.x · Cited by 139
Marinaccio, A., Binazzi, A., Marzio, D. D., Scarselli, A., Verardo, M., Mirabelli, D., Gennaro, V., Mensi, C., Riboldi, L., Merler, E., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.26229 · Cited by 138
Anti‐mesothelial markers in sarcomatoid mesothelioma and other spindle cell neoplasms
Attanoos, R. L., Dojcinov, S. D., Webb, R., & Gibbs, A. R. (2000) · Histopathology · doi:10.1046/j.1365-2559.2000.00981.x · Cited by 128
Henderson, D. W., Reid, G., Kao, S. C.-H., van Zandwijk, N., & Klebe, S. (2013) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2012-201303 · Cited by 124
Marinaccio, A., Montanaro, F., Mastrantonio, M., Uccelli, R., Altavista, P., Nesti, M., Costantini, A. S., & Gorini, G. (2005) · International Journal of Cancer · doi:10.1002/ijc.20820 · Cited by 123
Monaco, S. E., Shuai, Y., Bansal, M., Krasinskas, A. M., & Đačić, S. (2011) · American Journal of Clinical Pathology · doi:10.1309/ajcpp5r2zjzkclwn · Cited by 118
Tumors of the Serosal Membranes
Churg, A., Cagle, P. T., & Roggli, V. L. (2006) · American Registry of PathologyWashington, DC eBooks · doi:10.55418/1881041972 · Cited by 112
The Separation of Benign and Malignant Mesothelial Proliferations
Churg, A., & Galateau-Sallé, F. (2012) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2012-0112-ra · Cited by 109
Ordóǹez, N. G. (2012) · Human Pathology · doi:10.1016/j.humpath.2012.05.014 · Cited by 103
Sato, A., Torii, I., OKAMURA, Y., Yamamoto, T., Nishigami, T., Kataoka, T. R., Song, M., Hasegawa, S., Nakano, T., Kamei, T., et al. (2010) · Modern Pathology · doi:10.1038/modpathol.2010.134 · Cited by 80
BAP1 Protein is a Progression Factor in Malignant Pleural Mesothelioma
Arzt, L., Quehenberger, F., Halbwedl, I., Mairinger, T., & Popper, H. (2013) · Pathology & Oncology Research · doi:10.1007/s12253-013-9677-2 · Cited by 80
Ikeda, K., Tate, G., Suzuki, T., Kitamura, T., & Mitsuya, T. (2010) · Diagnostic Cytopathology · doi:10.1002/dc.21398 · Cited by 78
Takeda, M., Kasai, T., Enomoto, Y., Takano, M., Morita, K., Kadota, E., & Nonomura, A. (2010) · Pathology International · doi:10.1111/j.1440-1827.2010.02534.x · Cited by 77
Immunoreactivity for p53 protein in malignant mesothelioma and non‐neoplastic mesothelium
Ramael, M., Lemmens, G., Eerdekens, C., Buysse, C., Deblier, I., Jacobs, W., & Marck, E. V. (1992) · The Journal of Pathology · doi:10.1002/path.1711680406 · Cited by 76
Shi, M., Fraire, A. E., Chu, P. G., Cornejo, K. M., Woda, B. A., Dresser, K., Rock, K. L., & Jiang, Z. (2011) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e318218985b · Cited by 74
Takeshima, Y., Amatya, V. J., Kushitani, K., Kaneko, M., & Inai, K. (2009) · Histopathology · doi:10.1111/j.1365-2559.2009.03298.x · Cited by 71
Minato, H., Kurose, N., Fukushima, M., Nojima, T., Usuda, K., Sagawa, M., Sakuma, T., Ooi, A., Matsumoto, I., Oda, M., et al. (2014) · American Journal of Clinical Pathology · doi:10.1309/ajcp5knl7qtellyi · Cited by 67
Shen, J., Pinkus, G. S., Deshpande, V., & Cibas, E. S. (2009) · American Journal of Clinical Pathology · doi:10.1309/ajcpwfw7o1fvflkt · Cited by 64
Henderson, D. W., Reid, G., Kao, S., van Zandwijk, N., & Klebe, S. (2013) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2013-201609 · Cited by 60
Lee, A. F., Gown, A. M., & Churg, A. (2012) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31826ab1c0 · Cited by 58
Ikeda, K., Tate, G., Suzuki, T., Kitamura, T., & Mitsuya, T. (2010) · Human Pathology · doi:10.1016/j.humpath.2009.04.030 · Cited by 45
Sun, X., Wei, L., Lidén, J., Hui, G., Dahlman‐Wright, K., Hjerpe, A., & Dobra, K. (2005) · The Journal of Pathology · doi:10.1002/path.1810 · Cited by 39
Pinheiro, C. M., Longatto‐Filho, A., Soares, T. R., Pereira, H., BEDROSSIAN, C. W. M., Michael, C. W., Schmitt, F. C., & Baltazar, F. (2012) · Diagnostic Cytopathology · doi:10.1002/dc.22821 · Cited by 36
Lagana, S. M., Taub, R. N., & Borczuk, A. (2012) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2011-0219-oa · Cited by 35
Hwang, H. C., Tse, C. H., Rodriguez, S., Gown, A. M., & Churg, A. (2014) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000176 · Cited by 34
Aerts, J., Delahaye, M., van der Kwast, T., Davidson, B., Hoogsteden, H. C., & van Meerbeeck, J. P. (2006) · Diagnostic Cytopathology · doi:10.1002/dc.20486 · Cited by 32
Husain, A. N., Mirza, K., Gibbs, A. R., et al. (2014) · Lung Cancer · doi:10.1016/j.lungcan.2013.12.009 · Cited by 26
Expression and role of GLUT-1, MCT-1, and MCT-4 in malignant pleural mesothelioma
Mogi, A., Koga, K., Aoki, M., Hamasaki, M., Uesugi, N., Iwasaki, A., Shirakusa, T., Tamura, K., & Nabeshima, K. (2012) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-012-1344-6 · Cited by 23
Cited by
Husain, Colby, Ordóñez, Allen, Attanoos, Beasley, Butnor, Chirieac, Churg, Dacic, et al. (2018) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2017-0124-ra · Cited by 619
Mesothelioma: Scientific clues for prevention, diagnosis, and therapy
Carbone, M., Adusumilli, P. S., Alexander, H. R., Baas, P., Bardelli, F., Bononi, A., Bueno, R., Felley‐Bosco, E., Galateau‐Salle, F., Jablons, D., et al. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21572 · Cited by 335
ERS/EACTS statement on the management of malignant pleural effusions
Bibby, A. C., Dorn, P., Psallidas, I., Porcel, J. M., Janssen, J., Froudarakis, M., Subotic, D., Astoul, P., Licht, P., Schmid, R., et al. (2018) · European Respiratory Journal · doi:10.1183/13993003.00349-2018 · Cited by 316
Galateau-Salle, F., Churg, A., Roggli, V., & Travis, W. D. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2015.11.005 · Cited by 282
Novello, S., Pinto, C., Torri, V., Porcu, L., Di Maio, M., Tiseo, M., Ceresoli, G., Magnani, C., Silvestri, S., Veltri, A., et al. (2016) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2016.05.004 · Cited by 111
Self-citation
Metadata
- Authors
- Cigognetti, M., Lonardi, S., Fisogni, S., Balzarini, P., Pellegrini, V., Tironi, A., Bercich, L., Bugatti, M., Rossi, G., Murer, B., Barbareschi, M., Giuliani, S., Cavazza, A., Marchetti, G., Vermi, W., & Facchetti, F.
- Venue
- Modern Pathology
- Publisher
- Elsevier BV
- Published
- 2015-08
- Volume
- 28
- Issue
- 8
- Pages
- 1043-1057
- ISSN
- 0893-3952 (ISSN-L)
- OpenAlex
- W1659637636
- Cited by
- 306
- References
- 62
- FWCI
- 24.74
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.